Glenmark Pharmaceuticals informs about press release

15 Sep 2021 Evaluate

Glenmark Pharmaceuticals has informed that it attached a media release on September 2021 titled ‘Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFlu®) in 1000+ COVID-19 patients, findings reinforce the drug’s safety and efficacy in real world settings’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1179.80 19.95 (1.72%)
29-May-2024 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1489.80
Dr. Reddys Lab 6011.70
Cipla 1490.05
Zydus Lifesciences 1044.35
Lupin 1608.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.